|
English
|
正體中文
|
简体中文
|
Total items :0
|
|
Visitors :
52807887
Online Users :
535
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
|
|
|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 692886-692895 of 2348719 (234872 Page(s) Totally)
<< < 69284 69285 69286 69287 69288 69289 69290 69291 69292 69293 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2009 |
Prognostic Factors in Women with Early Stage Small Cell Carcinoma of the Uterine Cervix
|
黃昭源; 陳宇立; 朱鐵吉; 鄭文芳; 謝長堯; 林明杰; HUANG, CHAO-YUAN; CHEN, YU-LI; CHU, TIEH-CHI; CHENG, WEN-FANG; HSIEH, CHANG-YAO; LIN, MING-CHIEH |
| 臺大學術典藏 |
2020-11-27T08:14:21Z |
Prognostic factors in women with early stage small cell carcinoma of the uterine cervix
|
Huang C.-Y.; Chen Y.-L.; Chu T.-C.; Cheng W.-F.; CHANG-YAO HSIEH; Lin M.-C. |
| 臺大學術典藏 |
2018-09-10T18:07:07Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang, S.-K. and Lee, M.-R. and Liao, W.-Y. and Ho, C.-C. and Ko, J.-C. and Shih, J.-Y.; MENG RUI LEE; Wei-Yu Liao; Chao-Chi Ho; Jin-Yuan Shih; JEN-CHUNG KO; SHENG-KAI LIANG |
| 臺大學術典藏 |
2020-07-21T06:46:18Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Ko J.-C.; Shih J.-Y.; Liang S.-K.; Lee M.-R.; Liao W.-Y.; CHAO-CHI HO |
| 臺大學術典藏 |
2020-08-13T06:33:31Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Ko J.-C.;Jin-Yuan Shih; Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; Ko J.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-12T02:50:39Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Shih J.-Y.; Ko J.-C.; CHAO-CHI HO; Liang S.-K.;Lee M.-R.;Liao W.-Y.;Chao-Chi Ho;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Lee M.-R.; Liao W.-Y. |
| 臺大學術典藏 |
2021-01-08T03:40:20Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Shih J.-Y.; Ko J.-C.; Ho C.-C.; Liao W.-Y.; Lee M.-R.; SHENG-KAI LIANG |
| 臺大學術典藏 |
2021-03-11T07:58:28Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-03-11T08:34:19Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
| 臺大學術典藏 |
2021-10-04T07:15:41Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y. |
Showing items 692886-692895 of 2348719 (234872 Page(s) Totally)
<< < 69284 69285 69286 69287 69288 69289 69290 69291 69292 69293 > >>
View [10|25|50] records per page
|
